CRP and cutaneous mastocytosis: Findeisen et al. [34] used matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI–TOF–MS) and showed that serum amyloidal protein (SAA) and c-reactive protein (CRP) could serve as prognostic serum biomarkers for early-stage CM patients.